Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a randomized, double blinded, placebo-controlled, clinical phase III prevention trial studying Bifidobacterium animalis lactis BPL1 or Bifidobacterium animalis lactis BPL1 inactivated or placebo in 135 randomized abdominally obese individuals (1)
Change of abdominal visceral fat (abdominal visceral fat will be measured by Nuclear Magnetic Resonance (NMR))
The ingestion of Bifidobacterium animalis lactis BPL1 resulted in significant improvements in several health metrics. Notably, there was a decrease in waist circumference, the waist circumference/height ratio, and the Conicity index, all showing significant reductions compa…